Delivery Order SPE2DB22D1106-SPE2DB24FDQD3
Award Date 12/11/23
Potential Completion Date 12/12/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 400 mg/200 mL bottles of the pharmaceutical drug Ropivacaine 0.2%. The contract is a Delivery Order valued at $2,734.75 with a firm fixed price, and has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,572.03 firm fixed-price delivery order is for the supply of 400 mg/200 mL of Ropivacaine 0.2% solution, a medication used for pain management. The contract has an ultimate completion date of October 24, 2022 and was awarded on October 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,513.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. It is a firm fixed-price delivery order contract with a period of performance through July 2024. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen also holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $14,089.80, is for the delivery of 400 mg/200 mL Ropivacaine 0.2% injectable medication. The contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of November 16, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.03 firm fixed-price contract is for the delivery of 4567829319 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, with a period of performance through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,324.51, is for the delivery of 400 mg/200 ml of the medication Ropivacaine 0.2% in 200 ml vials. The contract has an ultimate completion date of January 30, 2025 and is a Firm Fixed Price Delivery Order. This contract is not associated with any set-aside designation. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,079.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 200 mg/100 mL solution, a local anesthetic medication. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical...
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 mL ropivacaine 0.2% in 200 mL doses, with a ceiling value of $6,449.98 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,304.95, is for the delivery of 400 mg/200 ml ropivacaine 0.2% solution, a medical product used for pain management. This is a firm fixed-price delivery order contract with a completion date of December 30, 2024. The contract is not set aside for any specific business type. AmerisourceBergen...